The first installment of our new predictive index shows that dealmakers expect overall M&A to increase, with health care outperforming the overall market READ MORE 


ACG New York Women of Leadership - Entrepreneur Series
Barbara Bradley Baekgaard, founder of Vera Bradley (Nasdaq: VRA), is the latest in a series of entrepreneurs highlighted at ACG New York Women of Leadership events. Photo credit: Robert Blumenfeld


GTCR, Hormel, the Riverside Co-CEOs and Others Win M&A Mid-Market Awards
Amid a slow and challenging year for dealmaking, the winners of Mergers & Acquisitions’ 7th Annual M&A Mid-Market Awards outpaced the competition to grow, innovate and lead the middle market


Financial Services Companies Heat Up M&A Market
Speakers from Flexpoint Ford, Genstar Capital, Baird Capital, Madison Capital Funding and Katten Muchin Rosenman discuss the various factors playing a role in M&A activity within the financial services space

Expert's Corner

Pursuing Pharma Manufacturing
The fragmented pharmaceutical manufacturing industry provides plenty of opportunities for private equity investors, says JLL Partners founder Paul Levy

Today's Transactions:
Perrigo Buys Pet Medication Co. for $160M

The target, Velcera, makes PetArmor flea and tick preventive medicine

Perrigo Co. (Nasdaq: PRGO) will acquire Velcera, a company that makes animal health products, for $160 million in cash.

Yardley, Pa.-based Velcera offers pet health products through its FidoPharm subsidiary, including PetArmor flea and tick preventive medicine, and other products.

Perrigo makes prescription and over-the-counter medication. In December, the company closed a deal for Cobrek Pharmaceuticals Inc. for $45 million.  The company, headquartered in Allegan, Mich., develops Aller-Ease, Nicotine Gum and Clear Lax.

Morgan Lewis & Bockius LLP served as legal counsel to Perrigo on the deal.

In September, Bayer AG agreed to buy Teva Pharmaceutical Industries Ltd.'s (NYSE: TEVA)'s health business for $145 million. 


For more information on related topics, visit the following: